Overexpression of miR-125a-5p attenuated epilepsy and decreased inflammatory factor levels in the hippocampus by suppressing calmodulin-dependent protein kinase IV (CAMK4), suggesting that miR-125a-5p might represent a novel treatment for epilepsy (Liu Q. et al., 2019). This evidence concerns the gene CAMK4 and epilepsy.